Cancer Research Institute takes part in Revlon LOVE IS ON Million Dollar Challenge

Cancer Research Institute (CRI) is proud to announce that it will be participating in the Revlon LOVE IS ON Million Dollar Challenge, which runs now through October 29, 2015.

The Revlon LOVE IS ON Million Dollar Challenge invites charities dedicated to three leading health issues facing women today—heart disease, women's cancers, and diabetes—to participate in an online fundraising challenge. The charity that raises the most donations for their cause over the course of six weeks will win an additional $1 million donation from Revlon.

The Cancer Research Institute is making an impact on women's health through its support of research aimed at developing immunotherapies for all cancers, including those that affect women worldwide most, such as breast, lung, and colorectal cancers.

The Revlon LOVE IS ON Million Dollar Challenge kicks off on September 21, when the Cancer Research Institute will begin encouraging its global community to donate and fundraise throughout the six weeks. Supporters of CRI can show their love for this cause in a few ways: directly donating to CRI through the Revlon challenge homepage, setting up a personal fundraising page on CrowdRise and linking to CRI, and encouraging others to join the campaign by sharing on their social media channels.

In addition to the grand prize of $1 million, Revlon will make a $250,000 donation to the runner-up charity. There will also be additional prizes distributed throughout the challenge to add to the excitement of the competition. The winner of the Revlon LOVE IS ON Million Dollar Challenge will be announced later this year.

"The Cancer Research Institute is looking forward to being part of the Revlon LOVE IS ON Million Dollar Challenge, an important campaign to improve women's health through awareness building and fundraising for worthy causes," said Jill O'Donnell-Tormey, Ph.D., CRI's chief executive officer and director of scientific affairs.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research suggests no need for yellow fever vaccine booster after initial dose